Current Affairs - Technology

Exercise : Technology - Latest Current Affairs
  • Technology - Latest Current Affairs
191.
Which institution conducted India’s first dedicated clinical trial of an advanced brain stent under the GRASSROOT trial?
PGIMER Chandigarh
AIIMS Delhi
CMC Vellore
NIMHANS Bengaluru
Answer: Option
Explanation:
AIIMS Delhi played a pioneering role by conducting India’s first dedicated clinical trial of an advanced brain stent under the GRASSROOT trial. The trial evaluated the safety and efficacy of the indigenously developed Supernova stent for treating severe strokes, particularly large vessel occlusion cases. Conducted across multiple medical centres, the study produced high-quality clinical evidence that led to CDSCO approval based solely on domestic data. This achievement strengthened India’s medical research ecosystem, reduced reliance on foreign trials, and supported national initiatives such as Make in India and Atmanirbhar Bharat in the medical devices sector.

192.
In which city did India launch its first indigenous hydrogen fuel cell passenger vessel for commercial service?
Kochi
Mumbai
Kolkata
Varanasi
Answer: Option
Explanation:
India’s first indigenous hydrogen fuel cell passenger vessel began commercial operations in Varanasi, specifically at Namo Ghat. The 24-meter catamaran, built by Cochin Shipyard Ltd. and owned by the Inland Waterways Authority of India, uses a Low Temperature Proton Exchange Membrane (PEM) fuel cell system, producing zero emissions and offering a sustainable transport solution along the Ganga. This initiative improves river-based mobility, reduces road congestion, supports eco-friendly tourism, and positions Varanasi as a leader in adopting futuristic green technologies under India’s Maritime Vision 2030 and Amrit Kaal Vision 2047.

193.
Which premier Indian institute is jointly hosting the Global AI Conclave in Chennai along with the India AI Mission?
IIT Delhi
IIT Bombay
IIT Madras
IISc Bengaluru
Answer: Option
Explanation:
IIT Madras is jointly hosting the Global AI Conclave in Chennai in collaboration with the India AI Mission, highlighting India’s growing role in shaping responsible artificial intelligence governance. The conclave focuses on advancing safe, trusted, and inclusive AI frameworks that are both globally interoperable and locally relevant. It brings together policymakers, industry leaders, academics, and civil society representatives to discuss AI safety, governance models, and collaborative initiatives such as an AI Safety Commons for the Global South. The event also serves as a key precursor to the India-AI Impact Summit 2026.

194.
What is the name of India’s first AI-powered platform launched for cybercrime investigations in Maharashtra?
CyberRakshak AI
MahaCrimeOS AI
CrimeNet India
Digital Suraksha Platform
Answer: Option
Explanation:
MahaCrimeOS AI is India’s first artificial intelligence–based platform developed specifically to support cybercrime investigations. The platform was unveiled in Maharashtra and has already been implemented in 23 police stations in Nagpur, with plans to expand its coverage to around 1,100 police stations across the state. By leveraging AI capabilities, the system is designed to enhance efficiency, data analysis, and investigative accuracy in handling cybercrime cases. This initiative reflects Maharashtra’s broader vision of adopting advanced AI solutions across sectors and positioning itself as a leading AI hub in India.

195.
What is the name of the AI framework developed to decode internal cancer-cell processes and predict tumour behaviour and growth patterns?
BioPredict
CancerScope
OncoMark
TumourSense
Answer: Option
Explanation:
OncoMark is an advanced artificial intelligence framework designed to analyze and interpret the internal processes of cancer cells. By decoding these complex biological mechanisms, it can forecast tumour behaviour and growth patterns with greater accuracy. Developed through collaborative research efforts and published in the journal Communications Biology, this tool helps bridge existing gaps in measuring key hallmarks of cancer during diagnosis. Its predictive capabilities support more personalized cancer treatment strategies, enabling clinicians to tailor therapies based on tumour characteristics, thereby improving diagnostic precision and potential treatment outcomes for cancer patients.